Eli Lilly’s Oral GLP-1 Approved, SpaceX Confidentially Files for IPO, Potential Activist Targets 4/1/26
Breaking this hour… Eli Lilly’s oral weight-loss pill approved by the FDA. What the company’s CEO told CNBC about the growth story. Then new reports say SpaceX has confidentially filed for an IPO. Plus, which companies could be the next target of an activist investor? Barclays with a new report looking at just that.
Audio is streamed directly from the publisher (dts.podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Breaking this hour… Eli Lilly’s oral weight-loss pill approved by the FDA. What the company’s CEO told CNBC about the growth story. Then new reports say SpaceX has confidentially filed for an IPO. Plus, which companies could be the next target of an activist investor? Barclays with a new report looking at just that.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.